1. Phase I study of evofosfamide, an investigational hypoxia‐activated prodrug, in patients with advanced leukemia. Issue 8 (25th June 2016) Authors: Badar, Talha; Handisides, Damian R.; Benito, Juliana M.; Richie, Mary Ann; Borthakur, Gautam; Jabbour, Elias; Harutyunyan, Karine; Konoplev, Sergej; Faderl, Stefan; Kroll, Stew; Andreeff, Michael; Pearce, Tillman; Kantarjian, Hagop M.; Cortes, Jorge E.; Thomas, Deborah A.; Konopleva, Marina Journal: American journal of hematology Issue: Volume 91:Issue 8(2016:Aug.) Page Start: 800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia. Issue 9 (31st August 2018) Authors: Ohanian, Maro; Garcia‐Manero, Guillermo; Levis, Mark; Jabbour, Elias; Daver, Naval; Borthakur, Gautam; Kadia, Tapan; Pierce, Sherry; Burger, Jan; Richie, Mary Ann; Patel, Keyur; Andreeff, Michael; Estrov, Zeev; Cortes, Jorge; Kantarjian, Hagop; Ravandi, Farhad Journal: American journal of hematology Issue: Volume 93:Issue 9(2018:Sep.) Page Start: 1136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial. Issue 1 (January 2019) Authors: Short, Nicholas J; Kantarjian, Hagop M; Loghavi, Sanam; Huang, Xuelin; Qiao, Wei; Borthakur, Gautam; Kadia, Tapan M; Daver, Naval; Ohanian, Maro; Dinardo, Courtney D; Estrov, Zeev; Kanagal-Shamanna, Rashmi; Maiti, Abhishek; Benton, Christopher B; Bose, Prithviraj; Alvarado, Yesid; Jabbour, Elias;... Journal: Lancet Issue: Volume 6:Issue 1(2019) Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗